COSCIENS Biopharma (CSCI) Inventory

Annual Inventory

$4.00 M
+$1.23 M+44.57%

December 1, 2023

Summary

Performance

1-Year Change

+44.57%

3-Year Change

+321.7%

5-Year Change

+666.94%

15-Year Change

+363.67%

CSCI Inventory Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

30.09%
CSCI annual inventory is higher than 30.09% of companies in Healthcare sector

High & Low

All-time High

$4.00 M
CSCI annual inventory is currently at an all-time high

3-Year Low

$1.82 M
CSCI annual inventory is currently +119.55% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
CSCI previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
CSCI next annual earnings announcement has not yet been scheduled

OtherCSCIbalance sheetmetrics:

Annual Total Assets

$23.70 M
CSCI annual total assets is $23.70 million

Annual Current Assets

$36.37 M
CSCI annual total current assets is $36.37 million

Annual Total Liabilities

$2.71 M
CSCI annual total liabilities is $2.71 million

Annual Current Liabilities

$4.54 M
CSCI annual total current liabilities is $4.54 million

Quarterly Inventory

$3.31 M
+$251.00 K+8.22%

September 1, 2024

Summary

Performance

3-Month Change

+8.22%

1-Year Change

-17.39%

3-Year Change

-17.39%

5-Year Change

-17.39%

CSCI Quarterly Inventory Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

27.87%
CSCI quarterly inventory is higher than 27.87% of companies in Healthcare sector

High & Low

All-time High

$4.00 M
CSCI quarterly inventory is currently -17.39% below its historical high of $4.00 million

3-Year Low

$1.40 M
CSCI quarterly inventory is currently +136.48% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CSCI previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
CSCI next earnings announcement has not yet been scheduled

OtherCSCIbalance sheetmetrics:

Quarterly Total Assets

$43.77 M
CSCI quarterly total assets is $43.77 million

Quarterly Current Assets

$28.22 M
CSCI quarterly total current assets is $28.22 million

Quarterly Total Liabilities

$23.75 M
CSCI quarterly total liabilities is $23.75 million

Quarterly Current Liabilities

$8.17 M
CSCI quarterly total current liabilities is $8.17 million

Inventory Formula

Inventory = Beginning Inventory + Purchases − Cost of Goods Sold

Annual Inventory

$4.00 M
CSCI annual inventory is $4.00 million

Annual Cost Of Goods Sold

$4.20 M
CSCI annual cost of goods sold is $4.20 million

CSCI Inventory Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+44.6%-17.4%
3 y3 years+321.7%-17.4%
5 y5 years+666.9%-17.4%

CSCI Inventory Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+119.5%-17.4%+136.5%
5 y5-yearat high+681.5%-17.4%+545.6%
alltimeall timeat high>+9999.0%-17.4%>+9999.0%

COSCIENS Biopharma Inventory History

DateAnnualQuarterly
Sep 2024
-
$3.31 M(+8.2%)
Jun 2024
-
$3.06 M(-13.6%)
Mar 2024
-
$3.54 M(-11.6%)
Dec 2023
$4.00 M(+44.6%)
$4.00 M(+1.3%)
Sep 2023
-
$3.95 M(+1.8%)
Jun 2023
-
$3.88 M(+23.7%)
Mar 2023
-
$3.14 M(+13.4%)
Dec 2022
$2.77 M(+51.9%)
$2.77 M(+53.9%)
Sep 2022
-
$1.80 M(+9.5%)
Jun 2022
-
$1.64 M(+17.5%)
Mar 2022
-
$1.40 M(-23.3%)
Dec 2021
$1.82 M(+92.1%)
$1.82 M(+51.7%)
Sep 2021
-
$1.20 M(+27.5%)
Jun 2021
-
$942.10 K(+19.1%)
Mar 2021
-
$791.30 K(-16.6%)
Dec 2020
$949.00 K(+85.3%)
$949.00 K(+6.6%)
Sep 2020
-
$890.30 K(-3.6%)
Jun 2020
-
$923.60 K(+28.8%)
Mar 2020
-
$717.00 K(+40.0%)
Dec 2019
$512.10 K(-1.9%)
$512.10 K(-30.1%)
Sep 2019
-
$732.10 K(+6.4%)
Jun 2019
-
$688.00 K(-5.2%)
Mar 2019
-
$725.40 K(+39.0%)
Dec 2018
$521.80 K(-39.5%)
$521.80 K(-17.7%)
Sep 2018
-
$634.10 K(-5.4%)
Jun 2018
-
$670.10 K(-21.1%)
Mar 2018
-
$849.80 K(-1.5%)
Dec 2017
$863.10 K(-2.0%)
$863.10 K(-4.2%)
Sep 2017
-
$900.50 K(-14.4%)
Jun 2017
-
$1.05 M(+12.4%)
Mar 2017
-
$936.30 K(+6.3%)
Dec 2016
$880.50 K(-1.7%)
$880.50 K(+40.8%)
Sep 2016
-
$625.20 K(-15.8%)
Jun 2016
-
$742.20 K(-15.5%)
Mar 2016
-
$878.50 K(-1.9%)
Dec 2015
$895.30 K(+53.0%)
$895.30 K(+18.4%)
Sep 2015
-
$755.90 K(-11.1%)
Jun 2015
-
$850.50 K(+23.7%)
Mar 2015
-
$687.30 K(+17.5%)
Dec 2014
$585.10 K(+92.5%)
$585.10 K(-26.3%)
Sep 2014
-
$794.10 K(+35.9%)
Jun 2014
-
$584.20 K(+74.4%)
Mar 2014
-
$335.00 K(+10.2%)
Dec 2013
$303.90 K(-61.7%)
$303.90 K(-31.2%)
Sep 2013
-
$441.70 K(-29.1%)
Jun 2013
-
$622.80 K(+33.1%)
Mar 2013
-
$467.90 K(-41.1%)
Dec 2012
$794.20 K(+17.3%)
$794.20 K(-13.2%)
Sep 2012
-
$915.30 K(+34.7%)
Jun 2012
-
$679.50 K(-16.3%)
Mar 2012
-
$812.00 K(+19.9%)
Dec 2011
$677.20 K
$677.20 K(+18.0%)
DateAnnualQuarterly
Sep 2011
-
$573.90 K(+0.6%)
Jun 2011
-
$570.40 K(+34.6%)
Mar 2011
-
$423.70 K(+51.6%)
Dec 2010
$279.40 K(-43.4%)
$279.40 K(-23.6%)
Sep 2010
-
$365.80 K(-9.7%)
Jun 2010
-
$405.20 K(-25.4%)
Mar 2010
-
$542.80 K(+10.0%)
Dec 2009
$493.60 K(+47.6%)
$493.60 K(+17.5%)
Sep 2009
-
$420.20 K(+2.2%)
Jun 2009
-
$411.00 K(+33.4%)
Mar 2009
-
$308.20 K(-7.8%)
Dec 2008
$334.40 K(+111.5%)
$334.40 K(-12.9%)
Sep 2008
-
$383.80 K(-15.0%)
Jun 2008
-
$451.50 K(+48.2%)
Mar 2008
-
$304.70 K(+92.7%)
Dec 2007
$158.10 K(+14.8%)
$158.10 K(-1.2%)
Sep 2007
-
$160.10 K(-20.5%)
Jun 2007
-
$201.40 K(-6.6%)
Mar 2007
-
$215.60 K(+56.6%)
Dec 2006
$137.70 K(-29.9%)
$137.70 K(-10.3%)
Sep 2006
-
$153.50 K(-9.8%)
Jun 2006
-
$170.20 K(+8.1%)
Mar 2006
-
$157.50 K(-19.8%)
Dec 2005
$196.50 K(-31.6%)
$196.50 K(-1.4%)
Sep 2005
-
$199.20 K(-9.7%)
Jun 2005
-
$220.70 K(-14.8%)
Mar 2005
-
$258.90 K(-9.9%)
Dec 2004
$287.30 K(+222.4%)
$287.30 K(-0.4%)
Sep 2004
-
$288.40 K(+122.4%)
Jun 2004
-
$129.70 K(+63.4%)
Mar 2004
-
$79.40 K(-10.9%)
Dec 2003
$89.10 K(+146.8%)
$89.10 K(+122.2%)
Sep 2003
-
$40.10 K(-9.9%)
Jun 2003
-
$44.50 K(-34.1%)
Mar 2003
-
$67.50 K(+87.0%)
Dec 2002
$36.10 K(-33.8%)
$36.10 K(+8.1%)
Sep 2002
-
$33.40 K(+15.2%)
Jun 2002
-
$29.00 K(-64.2%)
Mar 2002
-
$81.00 K(+48.6%)
Dec 2001
$54.50 K(+28.5%)
$54.50 K(+4.8%)
Sep 2001
-
$52.00 K(+16.9%)
Jun 2001
-
$44.50 K(-16.7%)
Mar 2001
-
$53.40 K(+25.9%)
Dec 2000
$42.40 K(-94.7%)
$42.40 K(-18.9%)
Sep 2000
-
$52.30 K(-61.3%)
Jun 2000
-
$135.00 K(+96.2%)
Mar 2000
-
$68.80 K(+1.5%)
Jun 1999
-
$67.80 K(-93.3%)
Sep 1997
-
$1.01 M(-17.7%)
Jun 1997
-
$1.23 M(+13.3%)
Mar 1997
-
$1.09 M
Dec 1996
$802.70 K
-

FAQ

  • What is COSCIENS Biopharma annual inventory?
  • What is the all time high annual inventory for COSCIENS Biopharma?
  • What is COSCIENS Biopharma annual inventory year-on-year change?
  • What is COSCIENS Biopharma quarterly inventory?
  • What is the all time high quarterly inventory for COSCIENS Biopharma?
  • What is COSCIENS Biopharma quarterly inventory year-on-year change?

What is COSCIENS Biopharma annual inventory?

The current annual inventory of CSCI is $4.00 M

What is the all time high annual inventory for COSCIENS Biopharma?

COSCIENS Biopharma all-time high annual inventory is $4.00 M

What is COSCIENS Biopharma annual inventory year-on-year change?

Over the past year, CSCI annual inventory has changed by +$1.23 M (+44.57%)

What is COSCIENS Biopharma quarterly inventory?

The current quarterly inventory of CSCI is $3.31 M

What is the all time high quarterly inventory for COSCIENS Biopharma?

COSCIENS Biopharma all-time high quarterly inventory is $4.00 M

What is COSCIENS Biopharma quarterly inventory year-on-year change?

Over the past year, CSCI quarterly inventory has changed by -$695.90 K (-17.39%)